Clinical study of RISS block in patients undergoing thoracoscopic lung cancer surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039311

Enrollment

Unknown

Registered

2020-10-23

Start date

2020-06-01

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

RISS group:RISS block

Paravertebral nerve block group:Paravertebral nerve block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. ASA I-III level; 2. Patients who plan to undergo thoracoscopic pulmonary space occupying surgery under general anesthesia by inserting double lumen bronchial catheter; 3. Patients who agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Subjects who took other experimental drugs or participated in other clinical trials within 3 months before the study; 2. Those who cannot cooperate with the research object for any reason; 3. Those who are younger than 14 years old; 4. It is not suitable to be included in this study; 5. Patients with block local skin infection and local sensory loss; 6. Pregnant patients.

Design outcomes

Primary

Measure	Time frame
VAS score;	—

Countries

China

Contacts

Public ContactGuixi Mo

Affiliated Hospital of Guangdong Medical University

mogxi@163.com+86 13763017403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026